Epistaxis Market To Surpass US$ 221.8 Million By 2027 - Coherent Market Insights


Posted July 31, 2020 by SANJAYCMI

“Coherent Market Insights “EPISTAXIS MARKET – GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027″
 
GLOBAL EPISTAXIS MARKET ANALYSIS
Global Epistaxis Market, by Product Type (Vasoconstrictors, Anesthetics, Antibiotic Ointments, and Cauterizing Agents), and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Epistaxis - A Common Clinical Condition
Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as interior of the nose is highly delicate and sensitive and cannot not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter.

In most cases, epistaxis responds effectively to nasal cauterization or nasal packaging or both. People experiencing recurrent sessions of nosebleeds are usually recommended to adopt surgical options or embolization procedures that are provided in the hospitals and ENT clinics. The most common treatment employed on the epistaxis patients is either chemical or electrical cautery. The method is easy to perform, cost effective, and does not involve any serious risk. Cauterization refers to a procedure, in which a small tissue at the bleeding site is removed or burnt with the help of chemicals such as silver nitrate or mild electric shocks.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/epistaxis-market-771

There are various topical applications such as tranexamic acid that is also available in the market, which helps to restrict nosebleeds. According to a research article published in the International Journal of Otolaryngology in 2015, epistaxis is estimated to affect around 10-12% of the total global population, of which, around 80% patients require medical attention as majority of epistaxis cases are not self-limiting and cannot be resolved due to intervention. Increasing number of cases in nosebleeds are thus expected to foster growth of the global epistaxis market.

The global epistaxis market was valued at US$ 130.0 million in 2016, and is expected to exhibit a CAGR of 5.7% over the forecast period (2017-2025).

Increasing prevalence of hypertension and change in environment are expected to drive the growth of the global epistaxis market

Rising cases of cardiovascular disorders, mainly hypertensive diseases, which are highly susceptible to hemorrhage are the leading causes of epistaxis. For instance, according to the Medical Statistics of World Health Organization in 2015, there were approximately 289,000 cases of hypertension recorded among pregnant women. Moreover, according to the American Pregnancy Organization, the circulatory system expands during pregnancy so as to accommodate the baby. The expansion leads to increase in creation and circulation of blood that may lead to problematic issues and frequent nosebleeds during pregnancy.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/771

Thus, rising number of pregnant women suffering from hypertensive diseases is expected to boost the global epistaxis market growth. Additionally, rising awareness among populace about the benefits of medical assistance for frequent bouts of bleeding is also expected to drive growth of the global epistaxis market. Furthermore, rising geriatric population, coupled with rapid technological development in the healthcare sector are expected to fuel the market growth over the forecast period.

However, side effects of cauterization procedures such as chemical allergies and pain, swelling, bruises, and running nose are expected to hinder the market growth over the forecast period.

Key players are focused in research and development for technological advancements and innovation of epistaxis products. For instance, in 2016, Smith & Nephew launched a range of epistaxis devices with RAPID RHINO technology that has a blend of carboxymethylcellulose (CMC) within them exhibiting self-lubricating properties that provide gentle and even compression to the nasal area and helps in the quicker re-conformation of the nasal anatomy. Various similar technological advancements and strategic implementations by emerging and established market players are expected to foster the global epistaxis market growth over the forecast period.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/771

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insigts
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags epistaxis , epistaxis market share , epistaxis market size
Last Updated July 31, 2020